Intermediate syndrome with delayed distal polyneuropathy from ethyl parathion poisoning. 1998

P Nisse, and X Forceville, and C Cezard, and A Ameri, and M Mathieu-Nolf
Centre Anti-Poisons de Lille, Centre Hospitalier Regional Universitaire de Lille, France.

An acute poisoning in a 44-y-old female who ingested 50 ml of ethyl parathion concentrate (25 g) is described. She was treated by gastric lavage, administration of pralidoxime and atropine, and mechanical ventilation. As signs of intoxication disappeared at day 3, treatment was discontinued. The patient had a relapse of acute cholinergic crisis at day 4, and the same treatment was applied again. The acute poisoning phase was followed by an intermediate syndrome and delayed distal polyneuropathy. The clinical course of this severe ethyl parathion poisoning was favorable after 40 d.

UI MeSH Term Description Entries
D007306 Insecticides Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. Insecticide
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D010278 Parathion A highly toxic cholinesterase inhibitor that is used as an acaricide and as an insecticide. E-605,Ethyl Parathion,Phosphostigmine,Thiofos,Thiophos,Parathion, Ethyl
D010523 Peripheral Nervous System Diseases Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves. Peripheral Nerve Diseases,Peripheral Neuropathies,PNS (Peripheral Nervous System) Diseases,PNS Diseases,Peripheral Nervous System Disease,Peripheral Nervous System Disorders,Nerve Disease, Peripheral,Nerve Diseases, Peripheral,Neuropathy, Peripheral,PNS Disease,Peripheral Nerve Disease,Peripheral Neuropathy
D011220 Pralidoxime Compounds Various salts of a quaternary ammonium oxime that reconstitute inactivated acetylcholinesterase, especially at the neuromuscular junction, and may cause neuromuscular blockade. They are used as antidotes to organophosphorus poisoning as chlorides, iodides, methanesulfonates (mesylates), or other salts. 2-PAM Compounds,Pyridine Aldoxime Methyl Compounds,2 PAM Compounds,Compounds, 2-PAM,Compounds, Pralidoxime
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D012121 Respiration, Artificial Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2). Ventilation, Mechanical,Mechanical Ventilation,Artificial Respiration,Artificial Respirations,Mechanical Ventilations,Respirations, Artificial,Ventilations, Mechanical
D002801 Cholinesterase Reactivators Drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. They are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates. Insecticides, Organophosphate, Antagonists,Insecticides, Organothiophosphate, Antagonists,Organophosphate Insecticide Antagonists,Organothiophosphate Insecticide Antagonists,Antagonists, Organophosphate Insecticide,Antagonists, Organothiophosphate Insecticide,Insecticide Antagonists, Organophosphate,Insecticide Antagonists, Organothiophosphate,Reactivators, Cholinesterase
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females

Related Publications

P Nisse, and X Forceville, and C Cezard, and A Ameri, and M Mathieu-Nolf
September 2013, Journal of pediatric intensive care,
P Nisse, and X Forceville, and C Cezard, and A Ameri, and M Mathieu-Nolf
January 2001, Intensive care medicine,
P Nisse, and X Forceville, and C Cezard, and A Ameri, and M Mathieu-Nolf
October 1993, Journal of neurology, neurosurgery, and psychiatry,
P Nisse, and X Forceville, and C Cezard, and A Ameri, and M Mathieu-Nolf
January 1992, Journal of toxicology. Clinical toxicology,
P Nisse, and X Forceville, and C Cezard, and A Ameri, and M Mathieu-Nolf
October 1992, Acta neurologica Scandinavica,
P Nisse, and X Forceville, and C Cezard, and A Ameri, and M Mathieu-Nolf
November 2011, Ethiopian journal of health sciences,
P Nisse, and X Forceville, and C Cezard, and A Ameri, and M Mathieu-Nolf
April 1985, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
P Nisse, and X Forceville, and C Cezard, and A Ameri, and M Mathieu-Nolf
May 2000, The Journal of the Association of Physicians of India,
P Nisse, and X Forceville, and C Cezard, and A Ameri, and M Mathieu-Nolf
January 2017, Internal medicine (Tokyo, Japan),
P Nisse, and X Forceville, and C Cezard, and A Ameri, and M Mathieu-Nolf
January 2002, Medical journal, Armed Forces India,
Copied contents to your clipboard!